Rosa Tellez-Moore finds hope and healing through groundbreaking research at UC San Diego Health Rosa Tellez-Moore is grateful ...

Victorian brain cancer researchers have achieved a global-first, using an innovative process to learn how a new drug ...

African Americans have been historically underrepresented in clinical trials, and California has taken steps to increase protections for research participants, while experts emphasize the importance ...

Like semaglutide, the new drug known as ecnoglutide is glucagon-like peptide-1 receptor agonist. In simple terms, they both ...

Testimony resumes Monday morning in the murder trial of Donna Adelson, a Florida matriarch accused of orchestrating a hit on her daughter’s ex. As CrimeOnline previously reported, Adelson, 75, is on ...

A 'Lebowski'-quoting cop, an accuser purportedly accosting a defendant in front of jurors —  not normal. A misdemeanor case ...

For decades, dentists and scientists have dreamed of helping people regrow lost teeth. Now, thanks to remarkable advances in ...

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc., in collaboration with Asher ...

In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s ...

In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight loss options after a 72-week period.